PhytoHealth Corporation

4108

TW0004108006

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
19.7 ^TWD	0.00%		-0.25%	-9.22%

05-07	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-27	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PhytoHealth Corporation Elects Wang Pai-Sen as a Director

May 24, 2023 at 03:19 am

PhytoHealth Corporation announced that at the Annual General Shareholders' Meeting held on May 24, 2023 approved election of Wang Pai-Sen,representative of Jen Yu Ltd. as a director.

Latest news about PhytoHealth Corporation

PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-06	CI
PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
PhytoHealth Corporation Signs MOU with Indena S.P.A. to Collaborate on Joint Development of Botanical Extracts for Phytohealth?s Research	02-23	CI
PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
PhytoHealth Corporation Announces the Resignation of Chen Wen-Hwa as Legal Representative and Director	23-09-14	CI
PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-31	CI
PhytoHealth Corporation Appoints Wu Yang-Chang as Independent Director	23-05-24	CI
PhytoHealth Corporation Elects Wang Pai-Sen as a Director	23-05-24	CI
PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28	CI
PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-08	CI
PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
PhytoHealth Corporation Announces R&D Progress of the One New Drugs Currently in Development	22-02-22	CI
PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-08	CI
Phytohealth Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-04	CI
PhytoHealth Corporation Announces Executive Changes	21-08-04	CI
PhytoHealth Corporation Announces Current R&D Progress on Anti-Osteoporosis	21-08-04	CI
PhytoHealth Corporation Announces Change of Research and Development Officer	21-07-30	CI
Phytohealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Phytohealth Corporation Announces Executive Changes, Effective May 11, 2021	21-05-11	CI
Phytohealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-24	CI
Phytohealth Corporation Announces Current R&D Progress on PG2, Anti-Osteoporosis, and Moderate to Severe Pain Relief New Drugs	21-02-23	CI
Phytohealth Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-12	CI

PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
PHYTOHEALTH CORPORATION	-9.22%	122M
CSL LIMITED	-0.07%	91.42B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	41.08B
BIOGEN INC.	-9.06%	34.26B
UCB	+55.32%	25.27B
BIOMARIN PHARMACEUTICAL INC.	-16.61%	15.27B
INCYTE CORPORATION	-9.14%	12.81B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.11%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.61%	11.42B
SWEDISH ORPHAN BIOVITRUM AB	+7.79%	9.16B

Biopharmaceuticals